Veracyte (VCYT) Tops Q4 EPS by 11c; Offers FY23 Revenue Guidance

Veracyte (NASDAQ: VCYT) reported Q4 EPS of ($0.05), $0.11 better than the analyst estimate of ($0.16). Revenue for the quarter came in at $80.3 million versus the consensus estimate of $74.94 million.

GUIDANCE:

Veracyte sees FY2023 revenue of $325-335 million, versus the consensus of $329.6 million.

For earnings history and earnings-related data on Veracyte (VCYT) click here.

You May Also Be Interested In

• Delta Air Lines (DAL) Tops Q2 EPS by 3c, Beats on Revenue; Offers Guidance
• Raymond James Previews Charles Schwab Corp. (SCHW) Earnings: 'Elevated Trading Volumes Drives Trading Revenue Upside'
• Wells Fargo previews Q2 midstream earnings, favors PAA and TRGP